Paisley Capital discloses 6.7% stake in Conexeu

Paisley Capital Holdings Corp reported a significant ownership position in Conexeu Sciences Inc. common stock.

Rhea-AI Filing Summary

Paisley Capital Holdings Corp reported a significant ownership position in Conexeu Sciences Inc. common stock. As of 06/30/2026, Paisley Capital beneficially owned 1,800,000 shares of Conexeu Sciences Inc. common stock, representing 6.7% of the class.

Paisley Capital, organized in the British Virgin Islands with a principal office in Baar, Switzerland, reported sole voting power and sole dispositive power over all 1,800,000 shares, with no shared voting or dispositive power. The certification section is marked as not applicable, and the filing is signed by Director Jacqueline Elsener on 07/16/2026.

Key Figures

Beneficial ownership: 1,800,000 shares Percent of class: 6.7% Sole voting power: 1,800,000 shares +3 more

6 metrics

Beneficial ownership 1,800,000 shares Common Stock of Conexeu Sciences Inc. beneficially owned by Paisley Capital

Percent of class 6.7% Portion of Conexeu Sciences Inc. common stock class held by Paisley Capital

Sole voting power 1,800,000 shares Shares over which Paisley Capital has sole power to vote or direct the vote

Sole dispositive power 1,800,000 shares Shares over which Paisley Capital has sole power to dispose or direct disposition

As-of date 06/30/2026 Date for which the ownership information is stated

Signature date 07/16/2026 Date the Schedule 13G was signed by Director Jacqueline Elsener

Key Terms

beneficially owned, sole voting power, dispositive power, percent of class

4 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 1,800,000"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"(i) Sole power to vote or to direct the vote: 1,800,000"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"(iii) Sole power to dispose or to direct the disposition of: 1,800,000"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class financial

"(b) | Percent of class: 6.7%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake does Paisley Capital hold in Conexeu Sciences Inc. (CNXU)?

Paisley Capital Holdings Corp beneficially owns 1,800,000 shares of Conexeu Sciences Inc. common stock, representing 6.7% of the class as reported in the Schedule 13G.

Does Paisley Capital have sole or shared voting power over CNXU shares?

Paisley Capital reports sole voting power over 1,800,000 shares of Conexeu Sciences Inc. common stock and no shared voting power over any shares.

What dispositive power does Paisley Capital report over CNXU stock?

Paisley Capital has sole dispositive power over 1,800,000 shares of Conexeu Sciences Inc. common stock and no shared dispositive power, meaning it alone can decide if and when to dispose of these shares.

Where is the CNXU shareholder Paisley Capital organized and located?

Paisley Capital Holdings Corp is a British Virgin Islands entity with its principal business office at Oberneuhofstrasse 5, Baar, Switzerland 6340, as disclosed in the Schedule 13G.

When was Paisley Capital’s CNXU ownership information dated and signed?

The beneficial ownership information is stated as of 06/30/2026, and the Schedule 13G was signed on 07/16/2026 by Director Jacqueline Elsener.

What class of Conexeu Sciences Inc. securities is reported in this Schedule 13G for CNXU?

The filing concerns Common Stock of Conexeu Sciences Inc., identified with CUSIP 20715F100, and details Paisley Capital’s beneficial ownership and control over these shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/20/2026 - 12:33 PM Accepted by SEC EDGAR 07/20/2026 - 12:33 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Conexeu Sciences Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

20715F100

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 20715F100

1

Names of Reporting Persons

Paisley Capital Holdings Corp

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

VIRGIN ISLANDS, BRITISH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,800,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,800,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,800,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.7 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Conexeu Sciences Inc.
(b)	Address of issuer's principal executive offices: 50 West Liberty Street, Suite 880, Reno, NV 89501
Item 2.
(a)	Name of person filing: Paisley Capital Holdings Corp
(b)	Address or principal business office or, if none, residence: Oberneuhofstrasse 5 Baar, Switzerland 6340
(c)	Citizenship: British Virgin Islands
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 20715F100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,800,000
(b)	Percent of class: 6.7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,800,000
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,800,000
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Paisley Capital Holdings Corp

Signature:	/s/ Jacqueline Elsener
Name/Title:	Director
Date:	07/16/2026